Satsuma Pharmaceuticals Inc (STSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 19,549 | 14,551 | 2,876 | 93,289 | 76,432 |
| Depreciation Amortization | 18,017 | 12,712 | 6,572 | 23,848 | 17,648 |
| Income taxes - deferred | 0 | N/A | N/A | 8,853 | N/A |
| Other Working Capital | -40,462 | -24,793 | 6,960 | -37,953 | -34,513 |
| Loans | 77 | 77 | 0 | -3,726 | -4,115 |
| Other Operating Activity | 111,088 | 71,805 | 38,798 | 38,007 | 20,458 |
| Operating Cash Flow | $108,269 | $74,352 | $55,206 | $122,318 | $75,910 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8,344 | -4,236 | -2,347 | -9,204 | -6,996 |
| Net Acquisitions | N/A | N/A | N/A | 92,419 | 92,419 |
| Purchase Of Investment | -1,169,000 | -384,426 | -401,156 | -414,949 | -200,360 |
| Sale Of Investment | 850,098 | 139,986 | 80,061 | 283,176 | 228,088 |
| Net Loans | -314,802 | -381,556 | -267,447 | -689,744 | -466,593 |
| Other Investing Activity | 8,170 | 1,804 | 1,721 | -978 | 1,428 |
| Investing Cash Flow | $-633,878 | $-628,428 | $-589,168 | $-739,280 | $-352,014 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -583 | 66,724 | 154,660 | 631,883 | 394,181 |
| Debt Issued | 780,245 | 779,750 | 714,000 | 2,246,244 | 1,517,744 |
| Debt Repayment | -680,505 | -585,457 | -486,046 | -2,133,187 | -1,630,642 |
| Common Stock Issued | 1,390 | 1,303 | 999 | 3,592 | 3,546 |
| Dividend Paid | -15,275 | -10,074 | -4,888 | -16,243 | -11,635 |
| Other Financing Activity | -21,194 | -21,966 | -22,030 | -36,504 | -34,109 |
| Financing Cash Flow | $459,609 | $540,339 | $519,707 | $632,875 | $264,795 |
| Beginning Cash Position | 194,478 | 194,478 | 194,478 | 178,565 | 178,565 |
| End Cash Position | 128,478 | 180,741 | 180,223 | 194,478 | 167,256 |
| Net Cash Flow | $-66,000 | $-13,737 | $-14,255 | $15,913 | $-11,309 |
| Free Cash Flow | |||||
| Operating Cash Flow | 108,269 | 74,352 | 55,206 | 122,318 | 75,910 |
| Capital Expenditure | -8,417 | -4,536 | -2,419 | -14,671 | -10,806 |
| Free Cash Flow | 99,852 | 69,816 | 52,787 | 107,647 | 65,104 |